Nxstage Pureflow Solution
by NxStage Medical, Inc. 2 variants
510(k) K033386
Nxstage Pureflow Solution is a medical device (FDA Class II; FDA product code KPO, Dialysate Concentrate For Hemodialysis (Liquid Or Powder)) made by NxStage Medical, Inc., cleared under FDA 510(k) K033386 on 26 Nov 2003, active as of 9 Oct 2026.
Active
510(k)
Valid until
No expiry
FDA recalls
None found
Documents
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK033386 | Date26 Nov 2003 | StatusActive |
Official records
- FDA 510(k) database K033386
From the FDA record
- Received by the FDA
- 23 Oct 2003
- FDA decision
- 26 Nov 2003 (Substantially Equivalent)
- FDA review time
- 34 days from receipt to decision
- Public document
- 510(k) summary on file with the FDA
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA product code
- KPO
- Device class
- Class II
- Regulation
- 21 CFR Part 876.5820
- Advisory committee
- Gastroenterology, Urology
- FDA decision
- SESE Substantially Equivalent
Similar devices
Other devices filed under FDA product code KPO (Dialysate Concentrate For Hemodialysis (Liquid Or Powder)).
- BICARBONATE CONCENTRATE POWDER by Haemolyte, Inc.
- DIALYSATE CONCENTRATE FOR HEMODIALYSIS by Cobe Laboratories, Inc.
- BIASOL LIQUID CONCENTRATES, ADD'L ACID CONCENTRATE by Baxter Healthcare Corp
- HEMODIALYSATE by EDLAW PHARMACEUTICALS, INC.
- HEMODIALYSIS CONCENTRATE SOLUTION by Mid Atlantic Nephrology Center
- DRYALYSATE CONCENTRATE by Advanced Renal Technologies, Inc.
- CHEM-DIALYTE CONCENTRATES by Luchem Pharmaceuticals, Inc.
- HOSPAL DIALYSATE FOR C.A.V.H.D. by Delmed, Inc.
- HEMODIALYSIS BATH CONCENTRATE SOLUTIONS FOR HEMODI by Dial Medical of Florida, Inc.
- DIALYSIS CONCENTRATE by Diversified Medical Services